Amaryllidaceae-Type Alkaloids from
Alkaloids
/ pharmacology
Amaryllidaceae
/ metabolism
Amaryllidaceae Alkaloids
/ pharmacology
Annexins
Apoptosis
Breast Neoplasms
/ drug therapy
Cell Cycle Checkpoints
Cell Line, Tumor
Cell Proliferation
Etoposide
/ pharmacology
Female
Galantamine
/ pharmacology
Humans
Reactive Oxygen Species
/ metabolism
Triple Negative Breast Neoplasms
/ drug therapy
bcl-2-Associated X Protein
/ metabolism
Pancratium maritimum
amaryllidaceae alkaloids
antiproliferative effect
apoptosis
cell cycle
triple-negative breast cancer
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
06 Sep 2022
06 Sep 2022
Historique:
received:
27
07
2022
revised:
01
09
2022
accepted:
02
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
Aiming to find Amaryllidaceae alkaloids against breast cancer, including the highly aggressive triple-negative breast cancer, the phytochemical study of
Identifiants
pubmed: 36144504
pii: molecules27185759
doi: 10.3390/molecules27185759
pmc: PMC9501014
pii:
doi:
Substances chimiques
Alkaloids
0
Amaryllidaceae Alkaloids
0
Annexins
0
Reactive Oxygen Species
0
bcl-2-Associated X Protein
0
Galantamine
0D3Q044KCA
homolycorine
477-20-3
Etoposide
6PLQ3CP4P3
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Fundação para a Ciência e Tecnologia
ID : PTDC/MED-QUI/30591/2017
Organisme : Fundação para a Ciência e Tecnologia
ID : UIDB/50006/2020
Organisme : Fundação para a Ciência e Tecnologia
ID : SFRH/BD/130348/2017
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Eur J Med Chem. 2017 Mar 10;128:247-257
pubmed: 28189906
Bioorg Med Chem. 2020 Dec 1;28(23):115798
pubmed: 33038666
Bioorg Med Chem. 2018 Jan 15;26(2):421-434
pubmed: 29233614
Alkaloids Chem Biol. 2006;63:87-179
pubmed: 17133715
Phytomedicine. 2016 Aug 15;23(9):968-78
pubmed: 27387405
Biotechnol Adv. 2020 Jan - Feb;38:107337
pubmed: 30633954
Drug Discov Today. 2021 Jul;26(7):1721-1727
pubmed: 33745879
Int J Mol Sci. 2021 Jun 28;22(13):
pubmed: 34203270
IUBMB Life. 2020 May;72(5):855-871
pubmed: 31913572
Chem Biodivers. 2021 Jul;18(7):e2001047
pubmed: 34000082
Cells. 2019 Aug 22;8(9):
pubmed: 31443516
Future Med Chem. 2018 Apr 1;10(7):725-741
pubmed: 29570361
Cancers (Basel). 2022 Feb 21;14(4):
pubmed: 35205839
J Nat Prod. 2020 Mar 27;83(3):770-803
pubmed: 32162523
Bioorg Med Chem Lett. 2015 Sep 1;25(17):3556-9
pubmed: 26169128
Chem Biol Interact. 2017 Sep 25;275:121-132
pubmed: 28756149
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
J Med Chem. 1994 Jul 8;37(14):2185-9
pubmed: 8035425
Front Pharmacol. 2020 May 08;11:599
pubmed: 32457612
Pharmaceuticals (Basel). 2021 Aug 28;14(9):
pubmed: 34577562
Adv Enzyme Regul. 1984;22:27-55
pubmed: 6382953
Tetrahedron Lett. 1968 Sep;(43):4573-6
pubmed: 5678610
Front Oncol. 2020 Nov 25;10:578095
pubmed: 33324554
Int J Mol Sci. 2021 Dec 17;22(24):
pubmed: 34948368
Br J Pharmacol. 2018 Oct;175(20):3947-3962
pubmed: 30076608
Br J Pharmacol. 2021 Sep;178(18):3627-3647
pubmed: 33899955
Cancers (Basel). 2021 Aug 28;13(17):
pubmed: 34503172
Alkaloids Chem Biol. 2010;68:1-37
pubmed: 20334035
Eur J Med Chem. 2021 Jan 15;210:112985
pubmed: 33189435
Planta Med. 2018 Dec;84(18):1372-1379
pubmed: 29996165